Malaria mystery solved
11 January, 2018An international collaboration, led by Melbourne researchers, has solved a longstanding malaria mystery.
Nucleic acids and immunity
15 December, 2017 by Mansi GandhiDr Michael Gantier, Research Group Head, Nucleic Acids and Innate Immunity at the Hudson Institute in Melbourne, reflects on the latest developments in the field of infection and immunity and his lab's current focus and future plans.
Novel compound may restore immune response in melanoma patients
11 December, 2017A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017 held in Geneva, Switzerland.
Australian-developed risk scoring system predicts childhood leukaemia relapse
04 December, 2017Australian researchers have developed a new risk scoring system for children with leukaemia based on missing DNA fragments or ‘microdeletions’.
Australia and Sri Lanka partner for kidney research
20 November, 2017Australian and Sri Lankan medical researchers have forged a new action plan to investigate the causes of a particular form of chronic kidney disease.
Scientists grow genetically modified skin using stem cells
09 November, 2017Scientists have reconstructed a fully functional epidermis, covering approximately 80% of the total body surface area, for a seven-year-old patient with a genetic skin disease called Junctional Epidermolysis Bullosa (JEB).
Antibiotic-resistant staph infections occurring more in Australian communities, not hospitals
31 October, 2017Research led by ANU has found that the proportion of 'staph' infections resistant to antibiotics has increased in Australia since 2000, with most cases now occurring in the community rather than in hospitals.
MSD and UniQuest to jointly develop immuno-oncology therapies
30 October, 2017Global healthcare company MSD and the University of Queensland's commercialisation company, UniQuest, have partnered to develop a platform for new immuno-oncology therapies.
3D map of molecular scaffold SgK223 to help develop new cancer treatments
30 October, 2017Melbourne researchers have produced a three-dimensional (3D) map of a molecular 'scaffold' called SgK223, known to play a critical role in the development and spread of aggressive breast, colon and pancreatic cancers.
Study debunks understanding of young proteins
23 October, 2017 by Mari N. Jensen , UA College of ScienceA yeast protein that evolved from scratch can fold into a three-dimensional shape, contrary to the general understanding of young proteins, according to new research led by the University of Arizona.
Slip, slop, slap — and avoid midnight snacks
20 October, 2017 by Lauren DavisWe bet you never thought your mealtimes could affect the biological clock of your skin — or its ability to protect itself from the sun's rays.
Lead poisoning is the top risk factor for pre-eclampsia, says study
05 October, 2017Griffith University researchers have found that lead poisoning is a major risk factor for pre-eclampsia, a disease which kills over 75,000 women internationally each year and is responsible for 9% of all foetal deaths.
Alternative splicing changes may trigger cancer
25 September, 2017Researchers at Sanford Burnham Prebys have shown that alterations in alternative splicing may trigger cancer.
Deakin University and Chinese biotech company set up lab to develop cancer-detecting blood test
22 September, 2017Deakin University and Chinese biotech company Suzhou GenePharma have partnered to develop a blood test that can detect fatal diseases like pancreatic or lung cancer.
3D bone tissue developed
15 September, 2017Researchers have grown three-dimensional samples of mineralised bone from human mesenchymal stem cells without typical osteoinductive media.
